The impact of TP53 and RAS mutations on cerebellar glioblastomas
Аутори:Milinkovic, Vedrana P.
Gazibara, Milica K. Skender
Gacic, Emilija M. Manojlovic
Gazibara, Tatjana M.
Tanic, Nikola T.
Чланак у часопису
МетаподациПриказ свих података о документу
Cerebellar glioblastoma (cGBM) is a rare, inadequately characterized disease, without detailed information on its molecular basis. This is the first report analyzing both TP53 and RAS alterations in cGBM. TP53 mutations were detected in more than half of the samples from our cohort, mainly in hotspot codons. There were no activating mutations in hotspot codons 12/13 and 61 of KRAS and HRAS genes in cGBM samples but we detected alterations in other parts of exons2 and 3 of these genes, including premature induction of STOP codon. This mutation was present in 3 out of 5 patients. High incidence of RAS mutations, as well as significantly longer survival of cGBM patients compared to those with supratentorial GBM suggest that cGBM may have different mechanisms of occurrence. Our results suggest that inactivation of TP53 and MS may play an important role in the progression of cerebellar GBM. (C) 2014 Elsevier Inc. All rights reserved.
Кључне речи:Glioblastoma; Cerebellar glioblastoma; Immunohistochemistry
Извор:Experimental and Molecular Pathology, 2014, 97, 2, 202-207